Date: 2015-04-08
Type of information: Nomination
Compound:
Company: Domainex (UK)
Therapeutic area: Technology - Services
Type agreement: nomination
Action mechanism:
Disease:
Details: * On April 8, 2015, Domainex prepares for expansion as it announces the appointment of Barry Knight as Chief Financial Officer and Company Secretary, and Thomas Mander as Chief Operating Officer. Domainex is a privately-owned revenue-generating company. This drug discovery CRO provides services including medicinal chemistry, hit identification, assay development, cell biology and mode of action studies, DMPK testing and protein expression.
Barry Knight is a Chartered Accountant and brings extensive financial expertise to Domainex, having been an executive director for Life Sciences companies for more than 25 years. Barry was previously Finance Director of both Trigen Holdings plc and AIM-listed Fulcrum Pharma plc. Most recently he was COO at Kinapse Limited during a period of rapid growth and its partial sale to a VC investor. In addition to his role at Fulcrum Pharma , he has been involved in preparing two further companies for listing, and has considerable experience in securing private equity funding and driving mergers, acquisitions and divestments.
Tom Mander started his career as a senior scientist with Xenova plc before becoming a group leader managing high-throughput screening at Glaxo Wellcome. Tom has been involved in the contract drug discovery and the translational research sector for the past 16 years. He held operational, business development, and marketing roles at Evotec AG before taking executive management positions at Tripos Discovery Research ltd (Vice President of Business Development) and Asterand Plc (Vice President of Sales and Marketing) prior to the companies’ trade sales. He joins Domainex from the Early Discovery division of Charles River, formerly BioFocus, where he was Director of Business Development. Tom will have specific responsibility for leading the Domainex service division.
Financial terms:
Latest news:
